South China Venture Capital - aVenture Asset Manager Research
Location
Shenzhen, Guangdong, CN
Founded
2008
South China Venture Capital, based in Shenzhen, is a prominent private equity investment firm focusing on the Chinese market. The firm manages multiple fund management companies, including branches in Shenzhen and Tianjin. Their investment strategy spans various stages, with a particular emphasis on Series A, B, and C rounds.
The firm's portfolio includes notable companies in the biotechnology and pharmaceutical sectors. Key investments include Cullgen, Immunowake, and Inmagene Biopharmaceuticals, with total funding ranging from $20 million to $121 million. South China Venture Capital's expertise in these industries positions them as a valuable partner for innovative startups in the life sciences field.
South China Venture Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
